Cardiopulmonary Exercise Testing in Interstitial Lung Disease
1 other identifier
observational
58
1 country
1
Brief Summary
In patients with Interstitial lung diseases (ILD) dyspnea is the most often symptom. Pulmonary lung function tests often do not Show the dyspnea. Aim of the study is to evaluate cardiopulmonary exercise testing concerning therapeutic Monitoring in ILD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 31, 2013
CompletedFirst Submitted
Initial submission to the registry
November 9, 2015
CompletedFirst Posted
Study publicly available on registry
December 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2017
CompletedOctober 29, 2018
October 1, 2018
3.9 years
November 9, 2015
October 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Alveolar-arterial oxygen partial pressure difference (AaDO2) in cardipulmonary exercise testing in ILD
quarterly, three years
Interventions
Eligibility Criteria
patients with Interstitial lung diseases
You may qualify if:
- informed consent provided
- ILD
You may not qualify if:
- no informed consent
- no ILD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wissenschaftliches Institut Bethanien e.Vlead
- Roche Pharma AGcollaborator
Study Sites (1)
Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep and Respiratory Medicine
Solingen, North Rhine-Westphalia, 42699, Germany
Related Publications (3)
Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010 Aug;138(2):251-6. doi: 10.1378/chest.10-0194.
PMID: 20682528RESULTFell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ, Flaherty KR. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009 Mar 1;179(5):402-7. doi: 10.1164/rccm.200802-241OC. Epub 2008 Dec 12.
PMID: 19074597RESULTHagmeyer L, Herkenrath S, Anduleit N, Treml M, Randerath W. Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease. Lung. 2019 Dec;197(6):721-726. doi: 10.1007/s00408-019-00282-9. Epub 2019 Nov 1.
PMID: 31676976DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2015
First Posted
December 21, 2015
Study Start
October 31, 2013
Primary Completion
September 30, 2017
Study Completion
September 30, 2017
Last Updated
October 29, 2018
Record last verified: 2018-10